IP Library Granted Patent US 9,265,828
Granted Patent B2
US 9,265,828 · App. 14/272,720 · Granted Feb 23, 2016

Hydrogel implants with varying degrees of crosslinking

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,265,828
App. No.
14/272,720
Granted
Feb 23, 2016
Kind
B2
Abstract

The present disclosure relates to a hydrogel composition and methods of using the same. The hydrogel composition may include precursors that react with each other upon contact as well as precursors that react upon contact with an initiator. In embodiments, the resulting hydrogels may have varying levels of crosslinking with both denser and less dense regions.

Claims (12)

1. A kit comprising:

a first reactive precursor comprising electrophilic groups, a second reactive precursor comprising nucleophilic groups, and a separate initiated precursor comprising at least one vinyl group;

an initiator to initiate crosslinking of the separate initiated precursor; and

a device for introducing the first reactive precursor, the second reactive precursor, the separate initiated precursor, and the initiator to a body lumen.

2. The kit of claim 1 , further comprising an initiator mask to selectively expose the separate initiated precursor to the initiator.

3. The kit of claim 1 , wherein the first reactive precursor, the second reactive precursor, or both, comprise a core comprising a component selected from the group consisting of polyethylene glycol, polyethylene oxide, polyethylene oxide-co-polypropylene oxide, co-polyethylene oxide block copolymers, co-polyethylene oxide random copolymers, polyvinyl alcohol, poly(vinyl pyrrolidinone), poly(amino acids), dextran, chitosan, alginates, carboxymethylcellulose, oxidized cellulose, hydroxyethylcellulose, hydroxymethylcellulose, hyaluronic acid, albumin, collagen, casein, gelatin, and combinations thereof.

4. The kit of claim 1 , wherein the first reactive precursor possesses N-hydroxysuccinimide groups and the second reactive precursor possesses amine groups.

5. The kit of claim 1 , wherein the separate initiated precursor is selected from the group consisting of acrylic acid, methacrylic acid, phosphorylcholine containing monomers, furanone functional vinyl monomers, potassium sulfopropyl acrylate, potassium sulfopropyl methacrylate, n-vinyl pyrrolidone, hydroxyethyl methacrylate, vinyl monomers having a high refractive index, siloxane functional vinyl compounds, polyethylene glycol-silicone co-monomers having vinyl groups, tris acrylate, pyrrole, liquid crystalline vinyl monomers, liquid crystalline vinyl polymers, and combinations thereof.

6. The kit of claim 1 , wherein the initiator is selected from the group consisting of redox initiators, free radical initiators, radiation, and combinations thereof.

7. The kit of claim 6 , wherein the radiation is selected from the group consisting of heat, visible light, ultraviolet light, gamma ray, and electron beam.

8. The kit of claim 1 , wherein the device comprises an endoscope.

9. The kit of claim 1 , wherein the device comprises a balloon catheter.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2014
From: BENNETT, STEVEN; MAST, NATHANIEL; LAVIGNE, KEVIN; SKALLA, WALTER; SARGEANT, TIMOTHY; STOPEK, JOSHUA
To: COVIDIEN LP
Reel/Frame 032848/0595 →